In the future, multi-organ protective intervention strategies need to be developed by targeting the TLR4 pathway, clearing circulating LPS, and regulating the microbiota-immune axis to contain the uncontrolled inflammation and organ failure driven by microbial products in sepsis. The gene discussed is TLR4; the disease is Sepsis.